Acne, molluscum, atopic dermatitis, and other dermatological disorders can be detrimental to quality of life for children and their families.
Scassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.
Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.
Experts discuss enhancing patient outcomes, comparing clobetasol cream concentrations, and more.
Looking toward the future management of vitiligo, expert dermatologists close out their discussion on JAK inhibition and other novel therapy.
Biologics work by inhibiting inflammatory cytokines, but a small percentage of patients may experience “paradoxical psoriasis.”
Nada Elbuluk, MD, and David Rosmarin, MD, provide advice to physicians on the management of vitiligo.
Earn CME credit and learn how to optimize a multimodal treatment approach for hidradenitis suppurativa.
This review will explore various leukemia-related cutaneous findings and discuss the diagnosis and management of these conditions.
Decentralized clinical trials are emerging as a crucial avenue for transforming this gender bias and fostering inclusivity within health care research.
Increased COPD prevalence in patients with psoriasis likely reflects smoking correlation, according to researchers.
Renata Block, MMS, PA-C, interviews fellow colleagues to discuss conference highlights, Psoriasis Awareness Month, community advocacy, and more.
November is Hyperhidrosis Awareness Month, and dermatology clinicians are gearing up for another month of raising awareness to improve patient outcomes.
The congenital ichthyosis session the 2024 AAD Annual Meeting covered real-world patient cases and treatments on the horizon.
The most critical step is understanding what value precision medicine brings to your practice, and where it can have greatest impact from both a clinical and business perspective.
Zeichner reviewed his top 3 acne treatment pearls at the Fall Clinical Dermatology Conference for PAs and NPs.
This CME credit opportunity delves into the pathogenesis and management of hidradenitis suppurativa.
Allergan Aesthetics recently announced the fifth-year of its partnership with Girls Inc. Nkem Ugonabo, MD, MPH, and Adelle Infante recently spoke with Dermatology Times to discuss the importance of STEM and dermatology mentorship.
In case you missed it, this week we had news about the AHEAD atopic dermatitis treatment recommendations, positive long-term results for roflumilast cream 0.05% in pediatric patients, line-field optical coherence tomography for dermal fillers, and more.
Ted Lain, MD, MBA, FAAD discusses navigating the treatment paradigm for vitiligo.
Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.
In this expert Q&A, dermatologist Jeffrey Cizenski, MD, FAAD, offers perspectives on National Eczema Awareness Month and AbbVie's Under My Skin documentary.
The fully human monoclonal antibody is currently approved in more than 60 countries.
Terry Arnold, PA-C, shares a wide range of opportunities to take clinical experience to a different setting and tips to transition.
Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.
Aubrie Jones, PA-C, MMS, and Laura Bush, DMSc, PA-C, DFAAPA, discuss the role of the SDPA in supporting the growth and journeys of PAs at all stages.